Research Highlight | Published:


Aspirin for primary prevention of CVD: a matter of balance

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


    Original articles

    1. The ASCEND Study Collaborative Group. Effects of aspirin for primary prevention in persons with diabetes mellitus. N. Engl. J. Med. (2018)

    2. Gaziano, J. M. et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet (2018)

    Download references

    Author information

    Correspondence to Irene Fernández-Ruiz.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark